Saavedra, Kristel Jane S.

HRN: 18-16-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2026
CO-AMOXICLAV 625MG (TAB)
03/30/2026
04/05/2026
PO
625mg
TID
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines